| Literature DB >> 12973122 |
Alison W Loren1, Shashank Desai, Robert C Gorman, Lynn M Schuchter.
Abstract
Donor-derived melanoma is easily transmitted through organ transplants and is highly aggressive in transplant recipients. The best treatment-withdrawal or reduction of immunosuppression-permits tumor rejection but risks allograft rejection. In recipients of nonrenal allografts, the prognosis is particularly grim, with transmission rates and mortality approaching 100%. Retransplantation has been proposed as a possible strategy but has never been performed for a cardiac allograft. This is the first report of cardiac retransplantation and only the second case of retransplantation of any nonrenal organ. Our patient received a heart transplant from a donor found to have occult metastatic melanoma at autopsy. He underwent retransplantation 17 days later. Close clinical and radiographic follow-up reveal no evidence of melanoma 22 months after transplantation. Based on the rapid development of donor-derived melanoma in previous reports, our patient is likely to remain free of donor cancer. Retransplantation and low-dose immunosuppression may have been lifesaving.Entities:
Mesh:
Year: 2003 PMID: 12973122 DOI: 10.1097/01.TP.0000080561.31826.FE
Source DB: PubMed Journal: Transplantation ISSN: 0041-1337 Impact factor: 4.939